Post-Market Surveillance Documentation for Medical Device: An Overview
Post-Market Surveillance (PMS) documentation is evolving from a compliance-driven requirement to a proactive, data-driven function within the medical device lifecycle. Under the EU MDR and IVDR, manufacturers are expected to systematically collect and analyse real-world data, define signal-detection thresholds, and identify trends and emerging risks early.
As a result, organisations must establish structured PMS documentation frameworks that support decision-making across risk management, clinical or performance evaluation, and quality systems. Post-Market Surveillance Plans and Post-Market Surveillance Reports play a key role in improving traceability, strengthening benefit-risk evaluation, and ensuring audit readiness across global markets. Post-Market Surveillance Plans are required in both the EU MDR and EU IVDR frameworks, with reporting structures varying by device classification.
Freyr brings deep regulatory expertise and structured methodologies to PMS documentation, supporting manufacturers in establishing robust, compliant frameworks aligned with EU MDR and EU IVDR expectations. By combining regulatory insight with systematic data evaluation approaches, Freyr enables improved traceability, stronger signal detection, and consistent lifecycle compliance.
Freyr’s Post-Market Surveillance Documentation Services
Freyr supports manufacturers with end-to-end PMS documentation services, including the development, evaluation, and maintenance of Post-Market Surveillance Plans (PMSP) and Post-Market Surveillance Reports (PMSR). Our approach combines regulatory expertise with structured documentation methodologies to ensure compliance with EU MDR and IVDR requirements, enable effective post-market data analysis, strengthen benefit-risk evaluation, and ensure audit-ready documentation across the product lifecycle. Our Core PMS Documentation Services include :
Post Market Surveillance Plan (PMSP)
The Post-Market Surveillance Plan (PMSP) defines how post-market data will be systematically collected and analyzed to monitor device performance. It is required under EU MDR Article 84 and Annex III, and EU IVDR Article 79 and Annex III, and must be established for each device or device family as part of technical documentation. A robust Post-Market Surveillance Plan outlines key data sources such as complaints, vigilance data, clinical or performance evidence, literature, registries, and user feedback, and establishes evaluation methodologies including signal detection criteria, threshold values, and structured trend analysis. It also defines communication channels with healthcare professionals or users and specifies how outputs are translated into Post-Market Surveillance Reports, Periodic Safety Update Reports, or corrective and preventive actions. Post-Market Surveillance Plans are consistently required across both MDR and IVDR frameworks.
Freyr supports manufacturers in developing structured and compliant Post-Market Surveillance Plans aligned with Annex III requirements. Our approach incorporates proactive surveillance methodologies, clearly defined thresholds, and integrated evaluation frameworks, enabling early signal detection, effective risk management, and sustained regulatory compliance.
Post Market Surveillance Report (PMSR)
The Post-Market Surveillance Report (PMSR) provides a structured summary of PMS activities and demonstrates how post-market data support the continued safety and performance of the device. It is required for Class I devices under EU MDR Article 85 and forms part of the technical documentation. The PMSR includes data analysis, trend and emerging risk identification, updated benefit-risk conclusions, and documentation of corrective actions. Under IVDR, PMS reporting applies to Class A and B devices, while higher-risk devices require PSUR.
Freyr supports the development of Post-Market Surveillance Reports by transforming complex post-market data into clear, structured, and audit-ready documentation. Our approach ensures accurate trend analysis, robust benefit-risk evaluation, and alignment with regulatory expectations, enabling manufacturers to demonstrate effective PMS performance during inspections and submissions.
PMS Documentation Gap Assessment
PMS documentation gap assessment enables manufacturers to evaluate the completeness and effectiveness of existing PMS documentation against EU MDR and EU IVDR requirements. This includes reviewing document structure, data collection approaches, and evaluation methodologies to identify gaps and areas for improvement.
Freyr conducts structured gap assessments supported by remediation roadmaps, enabling manufacturers to strengthen documentation quality, improve regulatory alignment, and prepare effectively for audits and notified body reviews.
PMS Documentation Maintenance & Lifecycle Updates
PMS documentation must be continuously maintained to reflect new insights generated from post-market activities, including complaints, vigilance data, clinical findings, and trend analyses. Regular updates ensure that documentation reflects current device performance and supports ongoing benefit-risk evaluation.
Freyr supports ongoing PMS documentation maintenance by ensuring that updates align with quality management systems. Our approach integrates new data into Post-Market Surveillance Plans and Post-Market Surveillance Reports, supports benefit-risk reassessment, and ensures audit readiness while aligning PMS outputs with management review and broader quality system processes, enabling continuous regulatory compliance and informed decision-making.
PMSP vs PMSR vs PSUR (EU MDR & IVDR Framework)
Under EU MDR and IVDR, Post-Market Surveillance (PMS) documentation is structured around key deliverables that define how post-market data is collected, evaluated, and reported throughout the device lifecycle. Articles 83–86 of the EU MDR and the corresponding IVDR provisions establish requirements for Post-Market Surveillance Plans, Post-Market Surveillance Reports, and Periodic Safety Update Reports (PSUR), while Annex III provides detailed guidance on the structure and content of the documentation.
| Document | Purpose | Device Class | MDR / IVDR Reference |
|---|---|---|---|
| PMS Plan (PMSP) | Defines data collection and evaluation methodology | All devices / IVDs | MDR Art. 84 / IVDR Annex III |
| PMS Report (classification-based under MDR & IVDR) | Summarises PMS results | Class I (MDR), Class A-B (IVDR) | MDR Art. 85 / IVDR Art. 80 |
| PSUR | Periodic safety evaluation | Class IIa+ (MDR), Class C-D (IVDR) | MDR Art. 86 / IVDR Art. 81 |
Book a meeting with our experts today
- Schedule a call today
Post-Market Surveillance Documentation
- Extensive experience across multiple medical device and IVD classes and global markets
- Strong understanding of EU MDR and EU IVDR PMS documentation expectations and audit requirements
- Proven capability in developing Post-Market Surveillance Plans and Reports aligned with Annex III
- Integration of PMS documentation with clinical evaluation and risk management processes
- Experience in handling large-scale and complex documentation programs
- Multilingual capabilities supporting global regulatory submissions
- Structured, SOP-driven documentation ensuring consistency and quality
- Delivery of audit-ready documentation aligned with regulatory expectations
- Strong focus on data traceability and clarity
- Scalable engagement models for project-based and ongoing needs
- Efficient turnaround with high-quality output
- Ability to support multi-market regulatory requirements
Why Partner with Freyr?
- Proven expertise in Post-Market Surveillance Plan (PMSP) and Post-Market Surveillance Report (PMSR) development
- Strong regulatory alignment with EU MDR and EU IVDR post-market surveillance requirements
- Integrated approach across quality, risk, and clinical processes
- Dedicated PMS documentation experts with notified body experience
- Flexible engagement models tailored to client needs
- Global delivery capabilities ensuring seamless execution
Frequently Asked Questions (FAQs)
01. What is a Post-Market Surveillance Plan (PMSP) for medical devices and IVDs?
A Post-Market Surveillance Plan (PMSP) is a structured document that defines how post-market data will be systematically collected, analysed, and used to monitor the safety and performance of medical devices and in vitro diagnostic (IVD) devices. Under the EU MDR (Article 84 and Annex III) and the EU IVDR (Article 78 and Annex III), the PMS Plan must include defined data sources, evaluation methodologies, and processes for identifying trends and implementing corrective actions throughout the product lifecycle.
02. What is the purpose of a Post-Market Surveillance Report (PMSR)?
A Post-Market Surveillance Report (PMSR) summarises the outcomes of post-market surveillance activities and demonstrates how collected data support the continued safety and performance of a device. Required for Class I devices under EU MDR (Article 85) and for Class A and B IVDs under IVDR (Article 80), it provides evidence of trend analysis, benefit-risk evaluation, and actions taken based on real-world performance data.
03. What is the difference between PMSP, PMSR, and PSUR?
The Post-Market Surveillance Plan (PMSP) defines the methodology for collecting and evaluating post-market data, while the PMS Report (PMSR) presents the results of those activities for lower-risk devices. For higher-risk devices, the Periodic Safety Update Report (PSUR) provides a more detailed and periodic evaluation of safety and performance under EU MDR Article 86 and IVDR Article 81.
04. What should be included in a Post-Market Surveillance Plan under EU MDR and EU IVDR?
A Post-Market Surveillance Plan should include clearly defined data sources such as complaints, vigilance data, and clinical evidence, along with methods for data evaluation, signal detection, threshold values, and trend analysis. It must also outline processes for corrective and preventive actions and demonstrate integration with risk management and clinical or performance evaluation in line with Annex III requirements.
05. How often should PMS documentation be updated?
PMS documentation should be continuously updated based on new information from post-market activities, including complaints, vigilance reports, and clinical data. Regulators expect ongoing review and timely updates to ensure documentation reflects the latest safety and performance insights.
06. How does PMS documentation support benefit-risk evaluation for medical devices and IVDs?
PMS documentation plays a critical role in ongoing benefit-risk evaluation by systematically collecting and analysing post-market data to identify trends, adverse events, and performance issues. These insights support reassessment of the benefit-risk balance and enable updates to risk management and clinical or performance evaluation documentation in line with EU MDR and EU IVDR requirements.
07. What are the key challenges in developing PMS Plans and PMS Reports under EU MDR and EU IVDR?
Common challenges include defining appropriate data sources, establishing robust evaluation methodologies, ensuring integration with risk management and clinical evaluation, and maintaining documentation aligned with evolving regulatory expectations. Manufacturers may also face challenges in implementing proactive surveillance processes and managing the increasing volume of post-market data across global markets.
07. Why is Freyr considered a preferred partner for PMS Plan (PMSP) and PMS Report (PMSR) services?
Freyr is recognised as a preferred partner for PMS documentation due to its strong regulatory expertise, structured approach to developing Post-Market Surveillance Plans (PMSP) and Post-Market Surveillance Reports (PMSR), and deep understanding of EU MDR and EU IVDR requirements. By integrating PMS with risk management and clinical or performance evaluation, and by delivering audit-ready documentation aligned with Annex III and global regulatory expectations, Freyr enables consistent compliance and confident regulatory outcomes.
